Emergent BioSolutions (EBS) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500 set to open near record highs as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.20 -0.55%
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
TMQ, OMH, AEHR, More
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
TMQ, OMH, AEHR, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.75, $0.13 better than the analyst estimate of $0.62. Revenue for the quarter came in at $270.7 million versus the consensus estimate of $270.03 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Highlights Two Machinery Names To Own
- Lamb Weston shares jump 3% on Q1 beat-and-raise
- Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
